An experimental, combination vaccine against ebola and Marburg viruses using virus-like particles provides complete protection against infection in monkeys. Traditionally vaccines against viral diseases have consisted of whole viruses, either the one that causes the disease in a weakened or dead state (like the polio vaccine) or a genetically similar virus that does not usually cause disease but elicits a protective immune response. The problem with this approach is there is the risk, however small, of viral reactivation and infection.
Recent comments
29 weeks 4 days ago